[Clinico-immunologic evaluation of the efficacy of bikarfen in allergic dermatoses].
It was found that the new native antihistamine and antiserotonin drug bicarphen possesses in patients with allergic dermatoses (eczema and neurodermatitis) more active antihistaminic, anti-inflammatory, antipruritic and antiallergic properties than commonly used drugs, particularly in cases with prevalence of exudative and allergic reactions of the immediate type. Normalization of rosette-forming T-lymphocytes and A and G immunoglobulins was essential.
Kashirskiĭ
Iu M
IuM
Kaminka
M E
ME
Nogaller
A M
AM
Fomin
K F
KF
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011812:Quinuclidines / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D011812:Quinuclidines; D012702:Serotonin Antagonists; C018139:bicarphene
Kliniko-immunologicheskaia otsenka éffektivnosti bikarfena pri allergicheskikh dermatozakh.